Waltham, MA · Founded 2015 · Privately Held (backing)
Developer of a biomedical software designed for advanced patient analysis and personalized therapy. BostonGene is based in Waltham, MA and was founded in 2015. Its last known valuation is $1.5 billion. It has raised $320 million.
Last price · $/share
—
Implied valuation
$1.5B
Total raised
$320.0M
Last round
—
Cap table — not yet on record
BostonGene's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BostonGene with a free account
·Watch BostonGene: the Monday email on marks, rounds and moves
